These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31428035)
1. Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study. Kim JY; Kim HJ; Choi HS; Park SY; Kim DY Front Neurol; 2019; 10():803. PubMed ID: 31428035 [No Abstract] [Full Text] [Related]
2. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke. Chang WH; Park CH; Kim DY; Shin YI; Ko MH; Lee A; Jang SY; Kim YH BMC Neurol; 2016 Mar; 16():31. PubMed ID: 26934986 [TBL] [Abstract][Full Text] [Related]
4. Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study. Lee S; Lee HH; Lee Y; Lee J J Rehabil Med; 2020 Feb; 52(2):jrm00025. PubMed ID: 32057086 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343 [No Abstract] [Full Text] [Related]
7. Cerebrolysin Combined with Rehabilitation Enhances Motor Recovery and Prevents Neural Network Degeneration in Ischemic Stroke Patients with Severe Motor Deficits. Chang WH; Lee J; Shin YI; Ko MH; Kim DY; Sohn MK; Kim J; Kim YH J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34208352 [TBL] [Abstract][Full Text] [Related]
8. Prospective, double blinded, comparative assessment of the pharmacological activity of Cerebrolysin and distinct peptide preparations for the treatment of embolic stroke. Zhang L; Chopp M; Wang C; Zhang Y; Lu M; Zhang T; Zhang ZG J Neurol Sci; 2019 Mar; 398():22-26. PubMed ID: 30665068 [TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Lang W; Stadler CH; Poljakovic Z; Fleet D; Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193 [TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z; Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation. Martinez RM J Med Life; 2017; 10(3):161-166. PubMed ID: 29075344 [TBL] [Abstract][Full Text] [Related]
12. Natural history of recovery from brain injury after prolonged disorders of consciousness: outcome of patients admitted to inpatient rehabilitation with 1-4 year follow-up. Katz DI; Polyak M; Coughlan D; Nichols M; Roche A Prog Brain Res; 2009; 177():73-88. PubMed ID: 19818896 [TBL] [Abstract][Full Text] [Related]
13. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke]. Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal Assessment of Clinical Signs of Recovery in Patients with Unresponsive Wakefulness Syndrome after Traumatic or Nontraumatic Brain Injury. Bagnato S; Boccagni C; Sant'Angelo A; Fingelkurts AA; Fingelkurts AA; Galardi G J Neurotrauma; 2017 Jan; 34(2):535-539. PubMed ID: 27149928 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke. Xue LX; Zhang T; Zhao YW; Geng Z; Chen JJ; Chen H Exp Ther Med; 2016 May; 11(5):2015-2020. PubMed ID: 27168844 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity and Specificity of the Coma Recovery Scale--Revised Total Score in Detection of Conscious Awareness. Bodien YG; Carlowicz CA; Chatelle C; Giacino JT Arch Phys Med Rehabil; 2016 Mar; 97(3):490-492.e1. PubMed ID: 26342571 [TBL] [Abstract][Full Text] [Related]
20. Assessment of Nociception and Pain in Participants in an Unresponsive or Minimally Conscious State After Acquired Brain Injury: The Relation Between the Coma Recovery Scale-Revised and the Nociception Coma Scale-Revised. Chatelle C; Hauger SL; Martial C; Becker F; Eifert B; Boering D; Giacino JT; Laureys S; Løvstad M; Maurer-Karattup P Arch Phys Med Rehabil; 2018 Sep; 99(9):1755-1762. PubMed ID: 29653106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]